detinfДЕТСКИЕ ИНФЕКЦИИCHILDREN INFECTIONS2072-81072618-8139Association of Pediatricians and Infection Disease doctors10.22627/2072-8107-2022-21-4-8-14detinf-768Research ArticleОРИГИНАЛЬНЫЕ СТАТЬИORIGINAL ARTICLESОсобенности течения СOVID-19 в сочетании с респираторным микоплазмозом у детейFeatures of the course of COVID-19 in combination with respiratory mycoplasmosis in childrenhttps://orcid.org/0000-0002-7557-2236ДрачеваН. А.DrachevaN. A.

Драчева Наталья Алексеевна, аспирант кафедры детских инфекционных болезней

Москва

N. Dracheva

Moscow

tan1809@mail.ruhttps://orcid.org/0000-0002-0895-6707МазанковаЛ. Н.MazankovaL. N.

Мазанкова Людмила Николаевна, д.м.н., профессор, зав. каф. детских инфекционных болезней педиатрического факультета, РМАНПО; гл. внештатный специалист по инфекционным болезням у детей

Москва

L. Mazankova, MD, Professor

Moscow

mazankova@list.ruhttps://orcid.org/0000-0003-0380-7515СамитоваЭ. Р.SamitovaE. R.

Самитова Эльмира Растямовна, к.м.н., зам. главного врача по инфекциям ГБУЗ «ДГКБ им. З.А. Башляевой»; ассистент каф. детских инфекционных болезней педиатрического факультета

Москва

E. Samitova, PhD

Moscow

samitova_rudn@mail.ruhttps://orcid.org/0000-0003-3181-9601ОсмановИ. М.OsmanovI. M.

Османов Исмаил Магомедтагирович, д.м.н., профессор, главный врач; гл. внештатный детский специалист-нефролог

Москва

I. Osmanov, MD, Professor

Moscow

osmanovim@zdrav.mos.ruhttps://orcid.org/0000-0001-7936-0399КлимоваО. И.KlimovaO. I.

Климова Ольга Ивановна, к.м.н., ассистент кафедры детских инфекционных болезней

Москва

O. Klimova, PhD

Moscow

oliaklimova@gmail.comhttps://orcid.org/0000-0002-9511-0995ДеминаО. И.DeminaO. I.

Демина Ольга Игоревна, к.м.н., ассистент кафедры детских инфекционных болезней

Москва

O. Demina, PhD

Moscow

demina91@mail.ruФГБОУ ДПО Российская медицинская академия непрерывного профессионального образования МЗ РФРоссияRussian Medical Academy of Continuing Professional Education of the Ministry of Health of the Russian FederationRussian FederationФГБОУ ДПО Российская медицинская академия непрерывного профессионального образования МЗ РФ; ГБУЗ «Детская городская клиническая больница имени З. А. Башляевой ДЗМ»РоссияRussian Medical Academy of Continuing Professional Education of the Ministry of Health of the Russian Federation; Children's City Clinical Hospital named after Z. A. BashlyaevaRussian FederationГБУЗ «Детская городская клиническая больница имени З. А. Башляевой ДЗМ»РоссияChildren's City Clinical Hospital named after Z. A. BashlyaevaRussian Federation202223112022214814Copyright © Драчева Н.А., Мазанкова Л.Н., Самитова Э.Р., Османов И.М., Климова О.И., Демина О.И., 20222022Драчева Н.А., Мазанкова Л.Н., Самитова Э.Р., Османов И.М., Климова О.И., Демина О.И.Dracheva N.A., Mazankova L.N., Samitova E.R., Osmanov I.M., Klimova O.I., Demina O.I.This work is licensed under a Creative Commons Attribution 4.0 License.https://detinf.elpub.ru/jour/article/view/768

В период пандемии COVID-19 сочетание инфекций, вызванных SARS-Cov-2 и M. рneumoniae является предметом повышенного внимания клиницистов. В данной статье представлено наблюдение 37 детей с COVID-19 в сочетании с респираторным микоплазмозом (РМ), целью которого было выявить особенности течения сочетанных инфекций по сравнению с моноинфекциями. По результатам исследования достоверно установлено сходство клинической картины поражения верхних и нижних дыхательных путей в группах сочетанных инфекций и моноинфекции COVID-19, что требует актуализации плана обследования и лечения в исследуемой когорте детей.

During the COVID-19 pandemic, the combination of infections caused by SARS-Cov-2 and M. rheimopiae is the subject of increased attention of clinicians. This article presents an observation of 37 children with COVID-19 in combination with respiratory mycoplasmosis (RM), the purpose of which was to identify the features of the course of combined infections compared with monoinfections. According to the results of the study, the similarity of the clinical picture of upper and lower respiratory tract lesions in the groups of combined infections and monoinfection COVID-19 was reliably established, which requires updating the examination and treatment plan in the study cohort of children.

детиSARS-CoV-2COVID-19Mycoplasma pneumoniaeреспираторный микоплазмозchildrenSARS-CoV-2COVID-19Mycoplasma pneumoniaerespiratory mycoplasmosisReferencesЗайцева С.В., Застрожина А.К., Муртазаева О.А. Микоплазменная инфекция у детей (обзор литературы). РМЖ. 2017; 5:327—334.Zaitseva S.V., Zastrozhina A.K., Murtazaeva O.A. Mycoplasma infection in children (literature review). RMJ. 2017; 5:327—334. (In Russ.)Waites K.B., Talkington D.F. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004; 17(4):697—728. doi: 10.1128/CMR.17.4.697-728.2004Waites K.B., Talkington D.F. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004; 17(4):697—728. doi: 10.1128/CMR.17.4.697-728.2004Gordon O., Oster Y., Michael-Gayego A., et al. The Clinical Presentation of Pediatric Mycoplasma pneumoniae Infections-A Single Center Cohort. Pediatr Infect Dis J. 2019; 38:698. doi: 10.1097/INF.0000000000002291Gordon O., Oster Y., Michael-Gayego A., et al. The Clinical Presentation of Pediatric Mycoplasma pneumoniae Infections-A Single Center Cohort. Pediatr Infect Dis J. 2019; 38:698. doi: 10.1097/INF.0000000000002291Спичак Т.В. Респираторная микоплазменная инфекция у детей: насколько мы продвинулись в решении проблем? Педиатрия. Журнал им. Г. Н. Сперанского. 2015; 6:128—133.Spichak T.V. Respiratory mycoplasma infection in children: how far have we progressed in solving problems? Pediatriа. The journal named after G. N. Speransky. 2015; 6:128—133. (In Russ.)Государственный доклад. М.: Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека, 2022:340.On the state of sanitary and epidemiological well-being of the population in the Russian Federation in 2021: State report. Moscow: Federal Service for Supervision of Consumer Rights Protection and Human Welfare, 2022:340. (In Russ.)Kutty P.K., Jain S., Taylor T.H., et al. Mycoplasma pneumoniae Among Children Hospitalized With Community-acquired Pneumonia. Clin Infect Dis. 2019; 68:5. doi: 10.1093/cid/ciy419Kutty P.K., Jain S., Taylor T.H., et al. Mycoplasma pneumoniae Among Children Hospitalized With Community-acquired Pneumonia. Clin Infect Dis. 2019; 68:5. doi: 10.1093/cid/ciy419Jain S., Williams D.J., Arnold S.R. Community-acquired pneumonia requiring hospitalization among US children. N Engl J Med. 2015. 372(9):835—845. doi: 10.1056/NEJMoa1405870Jain S., Williams D.J., Arnold S.R. Community-acquired pneumonia requiring hospitalization among US children. N Engl J Med. 2015. 372(9):835—845. doi: 10.1056/NEJMoa1405870Савенкова М.С., Савенков М.П. Респираторный микоплазмоз у детей. Лечебное дело. 2008; 1:9—14.Savenkova M.S., Savenkov M.P. Respiratory mycoplasmosis in children. Lechebnoye Delo. 2008; 1: 9—14. (In Russ.)Чихирева Л.Н., Черкашов А.М., Ли Е.Д., Чихирев О.А., Беленков Ю.Н. Вирусно-бактериальная ассоциация SARS-COV-2 с микоплазмой как одна из возможных причин тяжелых форм COVID-19. ЭиКГ. 2020; 179(7):143—151. doi: 10.31146/1682-8658-ecg-179-7-143-151Chikhireva L.N., Cherkashov A.M., Li E.D., Chikhirev O.A., Belenkov Yu.N. Viral bacterial association of SARS-COV-2 with mycoplasma as one of the possible causes of severe forms of COVID-19. EiKG. 2020; 179(7): 143—151. (In Russ.)Oliva A., Siccardi G., Migliarini A. et al. Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature. Infection. 2020; 48:871—877. doi: 10.1007/s15010-020-01483-8Oliva A., Siccardi G., Migliarini A. et al. Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature. Infection. 2020; 48:871—877. doi: 10.1007/s15010-020-01483-8Li Q, Guan X, Wu P, Wang X, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020 Mar 26; 382(13):1199—1207. doi: 10.1056/NEJMoa2001316Li Q, Guan X, Wu P, Wang X, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020 Mar 26; 382(13):1199—1207. doi: 10.1056/NEJMoa2001316Cai X, et al. Clinical manifestations and pathogen characteristics in children admitted for suspected COVID-19. Front Med. 2020 Dec; 14(6):776—785. doi: 10.1007/s11684-020-0820-7Cai X, et al. Clinical manifestations and pathogen characteristics in children admitted for suspected COVID-19. Front Med. 2020 Dec; 14(6):776—785. doi: 10.1007/s11684-020-0820-7Wu Q, Xing Y, Shi L, Li W, Gao Y, Pan S, Wang Y, Wang W, Xing Q. Coinfection and Other Clinical Characteristics of COVID-19 in Children. Pediatrics. 2020 Jul; 146(1):e20200961. doi: 10.1542/peds.2020-0961Wu Q, Xing Y, Shi L, Li W, Gao Y, Pan S, Wang Y, Wang W, Xing Q. Coinfection and Other Clinical Characteristics of COVID-19 in Children. Pediatrics. 2020 Jul; 146(1):e20200961. doi: 10.1542/peds.2020-0961Wanga V, Gerdes ME, Shi DS, et al. Characteristics and Clinical Outcomes of Children and Adolescents Aged < 18 Years Hospitalized with COVID-19 — Six Hospitals, United States, July-August 2021. MMWR Morb Mortal Wkly Rep. 2021 Dec 31; 70(5152):1766—1772. doi: 10.15585/mmwr.mm705152a3Wanga V, Gerdes ME, Shi DS, et al. Characteristics and Clinical Outcomes of Children and Adolescents Aged < 18 Years Hospitalized with COVID-19 — Six Hospitals, United States, July-August 2021. MMWR Morb Mortal Wkly Rep. 2021 Dec 31; 70(5152):1766—1772. doi: 10.15585/mmwr.mm705152a3Götzinger F, Santiago-García B, Noguera-Julián A, et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health. 2020 Sep; 4(9):653—661. doi: 10.1016/S2352-4642(20)30177-2Götzinger F, Santiago-García B, Noguera-Julián A, et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health. 2020 Sep; 4(9):653—661. doi: 10.1016/S2352-4642(20)30177-2Viner RM, Ward JL, Hudson LD, Ashe M, Patel SV, Hargreaves D, Whittaker E. Systematic review of reviews of symptoms and signs of COVID-19 in children and adolescents. Arch Dis Child. 2020 Dec 17. doi: 10.1136/archdischild-2020-320972Viner RM, Ward JL, Hudson LD, Ashe M, Patel SV, Hargreaves D, Whittaker E. Systematic review of reviews of symptoms and signs of COVID-19 in children and adolescents. Arch Dis Child. 2020 Dec 17. doi: 10.1136/archdischild-2020-320972Kim TY, Kim JY, Shim HJ, Yun SA, Jang JH, Huh HJ, Kim JW, Lee NY. Comparison of the PowerChek SARS-CoV-2, Influenza A&B, RSV Multiplex Real-time PCR Kit and BioFire Respiratory Panel 2.1 for simultaneous detection of SARS-CoV-2, influenza A and B, and respiratory syncytial virus. J Virol Methods. 2021 Dec; 298:114304. doi: 10.1016/j.jviromet.2021.114304Kim TY, Kim JY, Shim HJ, Yun SA, Jang JH, Huh HJ, Kim JW, Lee NY. Comparison of the PowerChek SARS-CoV-2, Influenza A&B, RSV Multiplex Real-time PCR Kit and BioFire Respiratory Panel 2.1 for simultaneous detection of SARS-CoV-2, influenza A and B, and respiratory syncytial virus. J Virol Methods. 2021 Dec; 298:114304. doi: 10.1016/j.jviromet.2021.114304Hoang A, Chorath K, Moreira A, Evans M, Burmeister-Morton F, Burmeister F, Naqvi R, Petershack M, Moreira A. COVID-19 in 7780 pediatric patients: A systematic review. EClinicalMedicine. 2020 Jun 26; 24:100433. doi: 10.1016/j.eclinm.2020.100433Hoang A, Chorath K, Moreira A, Evans M, Burmeister-Morton F, Burmeister F, Naqvi R, Petershack M, Moreira A. COVID-19 in 7780 pediatric patients: A systematic review. EClinicalMedicine. 2020 Jun 26; 24:100433. doi: 10.1016/j.eclinm.2020.100433Langford BJ, So M, Raybardhan S, Leung V, Westwood D, Mac-Fadden DR, Soucy JR, Daneman N. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020 Dec; 26(12): 1622—1629. doi: 10.1016/j.cmi.2020.07.016Langford BJ, So M, Raybardhan S, Leung V, Westwood D, Mac-Fadden DR, Soucy JR, Daneman N. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020 Dec; 26(12): 1622—1629. doi: 10.1016/j.cmi.2020.07.016Chotpitayasunondh T, Fischer TK, Heraud JM, Hurt AC, Monto AS, Osterhaus A, Shu Y, Tam JS. Influenza and COVID-19: What does co-existence mean? Influenza Other Respir Viruses. 2021 May; 15(3):407—412. doi: 10.1111/irv.12824Chotpitayasunondh T, Fischer TK, Heraud JM, Hurt AC, Monto AS, Osterhaus A, Shu Y, Tam JS. Influenza and COVID-19: What does co-existence mean? Influenza Other Respir Viruses. 2021 May; 15(3):407—412. doi: 10.1111/irv.12824Fan BE, Lim KGE, Chong VCL, Chan SSW, Ong KH, Kuperan P. COVID-19 and mycoplasma pneumoniae coinfection. Am J Hematol. 2020 Jun; 95(6):723—724. doi: 10.1002/ajh.25785Fan BE, Lim KGE, Chong VCL, Chan SSW, Ong KH, Kuperan P. COVID-19 and mycoplasma pneumoniae coinfection. Am J Hematol. 2020 Jun; 95(6):723—724. doi: 10.1002/ajh.25785Oliva A, Siccardi G, Migliarini A, Cancelli F, Carnevalini M, D'Andria M, Attilia I, Danese VC, Cecchetti V, Romiti R, Ceccarelli G, Mastroianni CM, Palange P, Venditti M. Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature. Infection. 2020 Dec; 48(6):871—877. doi: 10.1007/s15010-020-01483-8Oliva A, Siccardi G, Migliarini A, Cancelli F, Carnevalini M, D'Andria M, Attilia I, Danese VC, Cecchetti V, Romiti R, Ceccarelli G, Mastroianni CM, Palange P, Venditti M. Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature. Infection. 2020 Dec; 48(6):871—877. doi: 10.1007/s15010-020-01483-8Fang ZF, Sun BQ, Zhu AR, Lin LC, Zhao JC, He S, Huang SK, Zhong NS, Liu ZG. Multiplexed analysis of circulating IgA antibodies for SARS-CoV-2 and common respiratory pathogens in COVID-19 patients. J Med Virol. 2021 May; 93(5):3257—3260. doi: 10.1002/jmv.26829Fang ZF, Sun BQ, Zhu AR, Lin LC, Zhao JC, He S, Huang SK, Zhong NS, Liu ZG. Multiplexed analysis of circulating IgA antibodies for SARS-CoV-2 and common respiratory pathogens in COVID-19 patients. J Med Virol. 2021 May; 93(5):3257—3260. doi: 10.1002/jmv.26829Plebani A., A. Meini, M. Cattalini, V. Lougaris, A. Bugatti, F. Caccuri, A. Caruso, Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children. Clinical Immunology. 2020; 221:108613. doi: 10.1016/j.clim.2020.108613Plebani A., A. Meini, M. Cattalini, V. Lougaris, A. Bugatti, F. Caccuri, A. Caruso, Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children. Clinical Immunology. 2020; 221:108613. doi: 10.1016/j.clim.2020.108613

The authors declare that there are no conflicts of interest present.